Government of Canada
Symbol of the Government of Canada

The NRC Biotechnology Research Institute is known worldwide for its innovative research in Health, Bioprocess and Environment. The outstanding work of our researchers provides unique licensing opportunities for commercial partners.

LOD File
Number   
Description
PL-11725 Powerful Methylobacterium-based technology platform for the production of recombinant proteins and other bioproducts
PL-11565 HEK293 mammalian cell platform for high yield production of recombinant proteins, vaccines, and viral vectors
PL-11404 Protein expression technologies
L-12151 High sensitivity, early detection tool for toxic cyanobacterial blooms
L-12143 Electrolytically-enhanced anaerobic digestion (eAD) for high yield biogas production
L-12020 Novel algorithm for finding robust cancer gene markers
L-11993 A simple, scalable and high yield method for high level production of human recombinant interferon
L-11992 A more efficient and productive method for large-scale transfection of CHO cells
L-11947 Novel gene expression system for Escherichia coli
L-11927 New thermostable and catalytically-enhanced pectate lyase
L-11887 Muscle-mediated gene therapy
L-11885 Potent VEGF antagonists as potential therapeutic agents
L-11864 Eye drops for the delivery of an anti-glycation agent that prevents and treats diabetes- and age-related pathologies
L-11817 TGF-ß biologic targeted therapy for oncology, cardiovascular disease and nephrology indications
L-11808 Green process for the production of vinylguaiacol, a value-added product
L-11770 Enhanced system for baculovirus-mediated transient transgene expression
L-11727 Macrophage genes regulated by Ganoderma lucidum
L-11654 A new enantioselective and thermostable esterase for racemic resolution
L-11648 Cumate-inducible expression system in eukaryotic cells
L-11634 Multi-wavelength fluorometric system for on-line monitoring of bioprocesses
L-11622 A physical method for the quantification of viruses and viral particles
L-11615 Retractable bivalent polypeptide inhibitors
L-11565 Optimized large-scale transient gene expression with a serum-free suspension-growing HEK293 cell line
L-11498 Generating re-targeted adenoviral vectors with altered tropism
L-11444 A novel rapid and sensitive on/off switch regulated by coumarin for gene expression in mammalian cells
L-11434 Nucleic acid arrays for microorganisms detection and characterization
L-11425 Method for degradation of cyclic nitramines in contaminated soil, water or stockpiles
L-11391 Novel carrier proteins derived from Staphylococcus nuclease for high yield peptide production
L-11390 Versatile water electrolysis-based approach for integrated bioremediation of liquids contaminated with chlorinated and recalcitrant compounds
L-11388 Potent anticoagulants based on peptide inhibitors of thrombin
L-11323 Eye drops for the delivery of an anti-glycation agent that prevents and treats diabetes- and age-related pathologies
L-11320 Versatile and sterilizable probe for the extraction and quantification of volatile compounds in liquids
L-11313 Novel Baeyer-Villiger monooxygenases as useful biocatalysts
L-11266 Fast and high yield recombinant proteins production by large-scale transfection of suspension-growing mammalian cells
L-11136 Efficient method for the bioremediation of nitrate-contaminated groundwater
L-10894 A HEK293 cell line for suspension culture and serum-free production of recombinant proteins and viral vectors
L-10890 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants
L-10707 Immobilization of microorganisms in chitosan for environmental applications
L-10624 Simple and efficient method for the large-scale production of E1 deficient adenovirus
L-10344 Anaerobic and aerobic integrated system for biotreatment of toxic wastes
L-10269 Method for high-yield enzymatic synthesis of non-ionic biosurfactants